Adult Nodular Sclerosis Hodgkin Lymphoma Completed Phase 2 Trials for Panobinostat (DB06603)

IndicationStatusPhase
DBCOND0030887 (Adult Nodular Sclerosis Hodgkin Lymphoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01460940A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's LymphomaTreatment